120 Participants Needed

tACS for Aphasia

DS
DH
Overseen ByDenise Harvey, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Pennsylvania

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if transcranial alternating current stimulation (tACS) can improve language abilities in individuals with aphasia following a stroke. Participants will receive either real or sham tACS while engaging in language tasks, such as sentence completion and verb generation. The trial seeks individuals who have experienced a single stroke on the left side of the brain and continue to have language difficulties six months afterward. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research that could enhance language recovery methods.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, if you have a history of significant or poorly controlled psychiatric disorders or current abuse of alcohol or drugs, you may not be eligible to participate.

What prior data suggests that tACS is safe for enhancing language abilities in people with post-stroke aphasia?

Research shows that transcranial alternating current stimulation (tACS) is generally safe. Past studies demonstrated that tACS helps stroke patients recover more effectively. Importantly, these studies did not find any serious side effects. Most people tolerate tACS well, with mild side effects such as slight itching or tingling on the scalp. This suggests that tACS is a well-tolerated treatment option for improving language skills in those with post-stroke aphasia.12345

Why are researchers excited about this trial?

Unlike standard treatments for aphasia, which often rely on speech therapy and medications, transcranial alternating current stimulation (tACS) offers a unique approach by using electrical currents to stimulate brain activity. Researchers are particularly excited about tACS because it delivers alternating currents in the alpha frequency band, which may enhance language processing by directly influencing brain waves. This method is non-invasive and can be precisely targeted, potentially providing a new avenue for improving language skills in people with aphasia.

What evidence suggests that tACS is effective for enhancing language abilities in post-stroke aphasia?

Research shows that transcranial alternating current stimulation (tACS) might improve language skills in people with speech difficulties after a stroke. This trial will assign participants to receive either real-tACS or sham-tACS. An earlier study found that those who received tACS had better speech understanding and increased blood flow in their brains. This suggests that tACS could enhance brain function to aid in recovering language skills. Although the results are promising, further studies are needed to confirm its effectiveness specifically for language problems after a stroke. Overall, tACS appears to offer a new method to help stroke survivors regain their ability to speak.12367

Are You a Good Fit for This Trial?

This trial is for right-handed individuals who have had a stroke in the left hemisphere of their brain at least 6 months ago and are now experiencing aphasia, which affects language abilities. They must understand the study and agree to participate.

Inclusion Criteria

Must be able to understand the nature of the study, and give informed consent
My stroke happened more than 6 months ago.
I have difficulty with speaking or understanding language.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive real and sham transcranial alternating current stimulation (tACS) in conjunction with language tests

1 session
1 visit (in-person)

Follow-up

Participants are monitored for language performance improvement and brain response to tACS

5-10 minutes after treatment

What Are the Treatments Tested in This Trial?

Interventions

  • tACS
Trial Overview Researchers are testing if active transcranial alternating current stimulation (tACS) can improve language skills in people with post-stroke aphasia. Participants will undergo real and sham tACS while performing language tests to measure effectiveness.
How Is the Trial Designed?
2Treatment groups
Active Control
Placebo Group
Group I: real-tACSActive Control1 Intervention
Group II: sham-tACSPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pennsylvania

Lead Sponsor

Trials
2,118
Recruited
45,270,000+

Published Research Related to This Trial

A systematic review of five trials with 54 participants found no evidence that transcranial direct current stimulation (tDCS) improves speech and language therapy outcomes for stroke patients with aphasia.
While no adverse events were reported, the studies primarily measured picture naming rather than real-life communication, and cathodal tDCS over the non-lesioned hemisphere showed potential as a promising approach.
Transcranial direct current stimulation (tDCS) for improving aphasia in patients after stroke.Elsner, B., Kugler, J., Pohl, M., et al.[2022]
In a study of 37 stroke patients, speech therapy combined with transcranial direct current stimulation (tDCS) significantly improved language function, with an average increase in aphasia quotient (AQ%) of 14.94% after treatment.
Patients with less severe, fluent types of aphasia who started treatment within 30 days of their stroke showed the best responses, and those with hemorrhagic strokes had a higher likelihood of improvement compared to those with infarctions.
The Factors Associated with Good Responses to Speech Therapy Combined with Transcranial Direct Current Stimulation in Post-stroke Aphasic Patients.Jung, IY., Lim, JY., Kang, EK., et al.[2021]
Transcranial direct current stimulation (tDCS) combined with language training showed improved verb production in a 43-year-old male with fluent-anomic aphasia after a stroke, suggesting enhanced language recovery.
The study indicates that using tDCS over Broca's area during language therapy may effectively support brain plasticity and improve language skills in individuals with aphasia.
Translational treatment of aphasia combining neuromodulation and behavioral intervention for lexical retrieval: implications from a single case study.Galletta, EE., Vogel-Eyny, A.[2020]

Citations

The effect of transcranial alternating current stimulation on ...The results demonstrated that the tACS group had a significant decrease in mean NIHSS scores, a larger increase in blood flow velocity, and a ...
Transcranial Alternating Current Stimulation (tACS) in ...This study will assess the effects of transcranial alternating current stimulation (tACS) on language recovery after stroke as well as healthy language ...
Effect of transcranial direct current stimulation combined ...tDCS combined with SLT demonstrates potential enhancement in language recovery on post-ischemic stroke aphasia. The combination may augment speech content, ...
A single-blind sham-controlled study - Brain StimulationWe predicted that tACS over SMA would enhance the efficacy of SLT in chronic post-stroke aphasia, especially for improving speech comprehension.
Transcranial Alternating Current Stimulation (tACS) in ...This study will assess the effects of transcranial alternating current stimulation (tACS) on language recovery after stroke as well as healthy ...
NCT06092814 | tACS to Enhance Language AbilitiesThe goal of this study is to see if transcranial alternating current stimulation (tACS) can be used to enhance language abilities in people with post-stroke ...
Safety Review of transcranial Direct Current Stimulation in ...Only 11.62% of published papers reported the occurrence of tDCS adverse effects in stroke patients. The most common was itching (70%), followed by burning ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity